A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Phase 3
2,196
about 2.9 years
4+
157 sites in AL, AZ, CA +30
About this study
Researchers are testing whether a fixed dose combination of fluticasone propionate and albuterol sulfate, given as an inhaler, can help prevent severe asthma attacks. The trial will last for up to 35 months and involve adults and children with asthma.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Albuterol sulfate
- 2.Take TEV-56248
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Respiratory System Agent (Adrenergic beta2-Agonists)
inhaled
Secondary: Composite Responders Based on Asthma Quality of Life Questionnaire + 12 (AQLQ+12) or Pediatric AQLQ (PAQLQ), Number of Participants Who Withdrew From the Trial Due to Treatment-Emergent Adverse Events, Number of Participants with at Least One Adverse Event, Number of Participants with at Least One Serious Adverse Event
Respiratory